Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.
Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP.
Saif MW, et al. Among authors: nagar sp.
J Gastrointest Oncol. 2019 Aug;10(4):674-687. doi: 10.21037/jgo.2019.03.11.
J Gastrointest Oncol. 2019.
PMID: 31392048
Free PMC article.